AINDEX
Markets

DexCom, Inc. (DXCM)

DXCMNASDAQ-GSMedical/Dental Instruments

$79.92

-1.15 (-1.42%) today

At the close, Nov 10, 4:00 PM ET. After hours $79.92 –

-1.42% 1D
Market cap
$29.81bn
P/E
29.9
EPS, last 4 quarters
$2.67
Dividend yield
–
Day range
$79.18 to $81.07
52-week range
$54.20 to $92.59
Average volume
4.22m
Previous close
$81.07

Analysts

15 covering

Buy14 buy, 1 hold, 0 sell

Targets a year out average $99.56, +24.6% from here

$85.00now $79.92$120.00

Earnings

next estimate $0.7100

Next report

Dec 2025

+4.6%

Mar 2026

+19.1%

Jun 2026

+14.8%

Sep 2026

+10.6%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.26bn$1.19bn$1.31bn$1.34bn
Gross profit$792.70m$750.30m$830.00m$864.40m
Operating income$323.00m$255.30m$318.30m$327.20m
Net income$267.30m$199.50m$249.10m$275.10m

Last four quarters: revenue $5.10bn, margin 19.4%, free cash flow $1.10bn

News

8 latest

The company

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Sector
Health Care
Industry
Medical/Dental Instruments
Exchange
NASDAQ-GS
Region
North America
Website
dexcom.com

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.